Patrizia Mecocci
#134,547
Most Influential Person Now
Researcher
Patrizia Mecocci's AcademicInfluence.com Rankings
Patrizia Mecoccibiology Degrees
Biology
#9106
World Rank
#12271
Historical Rank
Biotechnology
#119
World Rank
#121
Historical Rank
Developmental Biology
#114
World Rank
#121
Historical Rank
Genetics
#924
World Rank
#1020
Historical Rank
Download Badge
Biology
Patrizia Mecocci's Degrees
- Masters Biology University of Milan
- Bachelors Biotechnology University of Bologna
Similar Degrees You Can Earn
Why Is Patrizia Mecocci Influential?
(Suggest an Edit or Addition)Patrizia Mecocci's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease (1994) (1068)
- Alzheimer's disease: clinical trials and drug development (2010) (1066)
- Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain (1993) (756)
- Common genetic variants influence human subcortical brain structures (2015) (731)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. (2005) (637)
- Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease (2003) (539)
- Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 (2014) (538)
- Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. (2003) (516)
- Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. (1999) (419)
- Potential markers of oxidative stress in stroke. (2005) (406)
- Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review (2015) (388)
- Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. (2010) (385)
- Validation of the Five‐Item Geriatric Depression Scale in Elderly Subjects in Three Different Settings (2003) (356)
- Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo (1995) (294)
- Plasma antioxidants and longevity: a study on healthy centenarians. (2000) (288)
- Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. (2015) (285)
- Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease. (2012) (248)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- Novel genetic loci associated with hippocampal volume (2017) (238)
- Antioxidant Profile and Early Outcome in Stroke Patients (2000) (237)
- Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. (2002) (236)
- Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease (2014) (234)
- Mild cognitive impairment: a systematic review. (2007) (229)
- Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness☆ (2014) (225)
- Neuropsychiatric Syndromes in Dementia (2007) (219)
- Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment (2009) (218)
- Common brain disorders are associated with heritable patterns of apparent aging of the brain (2019) (213)
- Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment (2011) (212)
- Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex (1999) (211)
- AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease (2009) (203)
- Plasma proteins predict conversion to dementia from prodromal disease (2014) (201)
- An ontology-based personalization of health-care knowledge to support clinical decisions for chronically ill patients (2012) (201)
- Novel genetic loci underlying human intracranial volume identified through genome-wide association (2016) (192)
- Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. (1997) (187)
- “Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool (2016) (184)
- Oxidative damage to DNA in lymphocytes from AD patients (1998) (181)
- Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. (2000) (180)
- Consistency of Neuropsychiatric Syndromes across Dementias: Results from the European Alzheimer Disease Consortium (2007) (180)
- Predictors of high level of burden and distress in caregivers of demented patients: results of an Italian multicenter study (2005) (173)
- Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. (2013) (173)
- Cognitive impairment: a key feature of congestive heart failure in the elderly (2003) (172)
- Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
- Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology (2014) (166)
- Mild Cognitive Impairment: Epidemiology and Dementia Risk in an Elderly Italian Population (2008) (162)
- Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls (2011) (148)
- High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. (2010) (148)
- Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (148)
- AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America (2011) (146)
- Age and sex influence on oxidative damage and functional status in human skeletal muscle (2004) (146)
- A Long Journey into Aging, Brain Aging, and Alzheimer’s Disease Following the Oxidative Stress Tracks1 (2018) (146)
- Education increases reserve against Alzheimer’s disease—evidence from structural MRI analysis (2012) (146)
- The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months (2011) (145)
- Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease (2011) (142)
- Elderly patients with cognitive impairment have a high risk for functional decline during hospitalization: The GIFA Study. (2005) (140)
- MRI Measures of Alzheimer's Disease and the AddNeuroMed Study (2009) (140)
- Tocopherols and tocotrienols plasma levels are associated with cognitive impairment (2012) (140)
- 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging (2001) (140)
- High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. (2009) (138)
- Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. (2002) (134)
- Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. (2012) (132)
- Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. (1999) (130)
- Plasma levels of lipophilic antioxidants in very old patients with Type 2 diabetes (2000) (125)
- Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease (2013) (122)
- Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis (2017) (122)
- Plasma Antioxidant Status, Immunoglobulin G Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia (2004) (122)
- Differential diagnosis of neurodegenerative diseases using structural MRI data (2016) (121)
- The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study (2005) (120)
- Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease (2011) (120)
- Different multivariate techniques for automated classification of MRI data in Alzheimer’s disease and mild cognitive impairment (2013) (117)
- Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease (2011) (116)
- Cognitive Impairment Is the Major Risk Factor for Development of Geriatric Syndromes during Hospitalization: Results from the GIFA Study (2005) (114)
- Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. (1998) (114)
- Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. (2013) (114)
- Nutraceuticals in cognitive impairment and Alzheimer’s disease (2014) (113)
- Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease (2010) (111)
- Physical activity and oxidative stress during aging. (2000) (110)
- Plasma Carotenoid and Malondialdehyde Levels in Ischemic Stroke Patients: Relationship to Early Outcome (2002) (109)
- Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy (2006) (109)
- Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge (2003) (109)
- Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease (2009) (104)
- Inflammatory biomarkers in Alzheimer's disease plasma (2019) (104)
- Mitochondrial genes are altered in blood early in Alzheimer's disease (2017) (104)
- Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. (2011) (104)
- Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease (2015) (101)
- Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults (2013) (101)
- The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume (2016) (99)
- Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity. (2002) (99)
- Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease (2016) (97)
- Circulating Proteomic Signatures of Chronological Age (2014) (96)
- Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project (2008) (96)
- Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity. (2004) (95)
- Plasma Vitamin C Levels Are Decreased and Correlated With Brain Damage in Patients With Intracranial Hemorrhage or Head Trauma (2001) (95)
- Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study (2005) (95)
- From cellular senescence to Alzheimer’s disease: The role of telomere shortening (2015) (95)
- Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment (2015) (94)
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease (2021) (94)
- Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. (2010) (94)
- Identification of cis-regulatory variation influencing protein abundance levels in human plasma. (2012) (89)
- Interaction between bone and muscle in older persons with mobility limitations. (2014) (89)
- Metabolic Syndrome and Risk of Dementia in Older Adults (2010) (88)
- Apathy and cortical atrophy in Alzheimer's disease (2011) (88)
- Heterogeneous patterns of brain atrophy in Alzheimer's disease (2018) (88)
- Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects (2008) (87)
- A blood gene expression marker of early Alzheimer's disease. (2013) (87)
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden (2012) (83)
- Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease? (1998) (81)
- Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis (2014) (81)
- Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer’s disease (2007) (81)
- A review of the major vascular risk factors related to Alzheimer's disease. (2012) (81)
- Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types (2008) (80)
- The reliability of a deep learning model in clinical out-of-distribution MRI data: a multicohort study (2019) (78)
- Insight, cognition and quality of life in Alzheimer's disease (2009) (78)
- Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment (2013) (76)
- Dietary habits are major determinants of the plasma antioxidant status in healthy elderly subjects (2005) (76)
- Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. (2004) (75)
- Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients (1999) (74)
- Hypertension and cognitive function in the elderly. (2007) (74)
- Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups—The AddNeuroMed study (2011) (72)
- Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α‐/γ‐tocotrienols and γ‐tocopherol (2013) (72)
- Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study (2019) (71)
- Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease (2010) (71)
- Blood‐brain‐barrier in a geriatric population: barrier function in degenerative and vascular dementias (1991) (70)
- Fatigue: Relevance and implications in the aging population (2015) (70)
- Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia (1995) (68)
- Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. (2004) (68)
- Diabetes drugs in the fight against Alzheimer's disease (2019) (68)
- Development of a short form of the Severe Impairment Battery. (2005) (67)
- The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults (2019) (67)
- Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post‐hoc analyses of ADAS‐cog and SIB total and single‐item scores from six randomized, double‐blind, placebo‐controlled studies (2009) (67)
- Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut‐offs (2014) (67)
- Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type (2004) (65)
- Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts (2014) (65)
- The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey (2015) (64)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics. (2012) (62)
- Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease. (2013) (62)
- Altered mitochondrial membrane fluidity in AD brain (1996) (61)
- Body mass index, lifestyles, physical performance and cognitive decline: The “Treviso Longeva (Trelong)” study (2013) (61)
- An MRI‐based index to measure the severity of Alzheimer's disease‐like structural pattern in subjects with mild cognitive impairment (2013) (60)
- Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort. (2008) (60)
- Predicting Progression of Alzheimer’s Disease Using Ordinal Regression (2014) (60)
- Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer’s dementia (2001) (60)
- Cognitive enhancement therapy for Alzheimer's disease. The way forward. (1997) (57)
- Axonal injury within language network in primary progressive aphasia (2003) (57)
- Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. (2008) (57)
- Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. (2011) (57)
- Protective variant for hippocampal atrophy identified by whole exome sequencing (2015) (56)
- Antioxidants for the treatment of mild cognitive impairment (2004) (55)
- Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
- Guidelines for the Treatment of Alzheimer’s Disease from the Italian Association of Psychogeriatrics (2005) (55)
- Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease (2016) (54)
- Validation Study of the Italian Addenbrooke’s Cognitive Examination Revised in a Young-Old and Old-Old Population (2012) (53)
- Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. (2010) (51)
- Nutrition and lifestyle in healthy aging: the telomerase challenge (2016) (49)
- Cognitive Performance in Elderly Patients Undergoing Carotid Endarterectomy or Carotid Artery Stenting: A Twelve-Month Follow-Up Study (2010) (48)
- APOE ε2 Allele Is Associated with Larger Regional Cortical Thicknesses and Volumes (2010) (47)
- Physical activity and inflammation: effects on gray‐matter volume and cognitive decline in aging (2016) (47)
- Elevated Lipid Peroxidation Biomarkers and Low Antioxidant Status in Atherosclerotic Patients with Increased Carotid or Iliofemoral Intima Media Thickness (2007) (45)
- HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease. (2012) (45)
- Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood (2014) (45)
- Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes (2015) (44)
- CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study. (2011) (43)
- Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status (2006) (42)
- Congestive heart failure and Alzheimer's disease (2006) (41)
- Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease (2016) (41)
- Vitamin E biotransformation in humans. (2007) (40)
- Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus. (2011) (39)
- Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease. (2015) (38)
- Depression in the elderly: new concepts and therapeutic approaches (2004) (38)
- Prevention of Age-Related Cognitive Decline: Which Strategies, When, and for Whom? (2015) (38)
- Fracture prevention service to bridge the osteoporosis care gap (2013) (38)
- Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease (2011) (38)
- Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition (2016) (37)
- A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis (2015) (37)
- Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease (2021) (37)
- CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study. (2014) (37)
- The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly (2016) (36)
- Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment. (2015) (36)
- Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting (2017) (36)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Plasma Levels of Complement 4a Protein are Increased in Alzheimer's Disease (2012) (35)
- Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons (2017) (35)
- Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease (2006) (35)
- COVID-19: A Geriatric Emergency (2020) (35)
- Blood homocysteine and risk of depression in the elderly. (2010) (35)
- Stability of graph theoretical measures in structural brain networks in Alzheimer’s disease (2018) (34)
- Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease. (2010) (34)
- Association between apolipoprotein E ɛ4 allele and apathy in probable Alzheimer's disease (2006) (34)
- Detecting frontotemporal dementia syndromes using MRI biomarkers (2019) (34)
- The Effect of Age Correction on Multivariate Classification in Alzheimer’s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects (2015) (33)
- FASTKD2 is associated with memory and hippocampal structure in older adults (2014) (33)
- Genetics of brain age suggest an overlap with common brain disorders (2018) (32)
- Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort (2014) (32)
- Proton Magnetic Resonance Spectroscopy Reveals Similar White Matter Biochemical Changes in Patients with Chronic Hypertension and Early Alzheimer's Disease (2002) (31)
- Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints (2014) (31)
- Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation (2012) (30)
- An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene (2020) (29)
- A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease (2017) (29)
- Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease. (2015) (29)
- Genetic Architecture of Subcortical Brain Structures in Over 40,000 Individuals Worldwide (2017) (28)
- Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort. (2010) (26)
- Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease (2019) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease (2011) (25)
- AUTOANTIBODIES AGAINST OXIDIZED LOW‐DENSITY LIPOPROTEINS IN OLDER STROKE PATIENTS (1997) (25)
- The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study (2017) (25)
- Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation (2012) (25)
- Beta-carotene, telomerase activity and Alzheimer’s disease in old age subjects (2020) (25)
- Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier (2018) (24)
- Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study (2019) (24)
- Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations (2015) (24)
- The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals (2017) (23)
- Effects of vitamin C and aspirin in ischemic stroke‐related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study (2005) (23)
- Cachexia and advanced dementia (2019) (23)
- Use of Artificial Networks in Clinical Trials: A Pilot Study to Predict Responsiveness to Donepezil in Alzheimer's Disease (2002) (23)
- Is multi‐infarct dementia representative of vascular dementias? A retrospective study (1990) (22)
- Rapidly Progressive Aphasic Dementia with Motor Neuron Disease: A Distinctive Clinical Entity (2003) (22)
- High Vitamin E Plasma Levels and Low Low‐Density Lipoprotein Oxidation Are Associated with the Absence of Atherosclerosis in Octogenarians (2001) (22)
- Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders (2021) (22)
- Vascular Risk Factors in Mild Cognitive Impairment Subtypes (2007) (22)
- Emotional and Psychological Distress of Persons Involved in the Care of Patients with Alzheimer Disease Predicts Falls and Fractures in Their Care Recipients (2010) (22)
- Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia (1993) (22)
- Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity (2007) (22)
- Vitamin E and Alzheimer’s disease: the mediating role of cellular aging (2019) (21)
- Genetic factors associated with the absence of atherosclerosis in octogenarians. (2002) (21)
- The genetic architecture of human brainstem structures and their involvement in common brain disorders (2019) (20)
- Healthy brain ageing and cognition: Nutritional factors (2016) (20)
- Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene (2011) (20)
- The local reliability of the 15-item version of the Geriatric Depression Scale: An item response theory (IRT) study. (2017) (20)
- Evaluating combinations of diagnostic tests to discriminate different dementia types (2018) (20)
- Hypertension and cognitive function in the elderly. (2010) (19)
- Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study. (2019) (19)
- Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias (1992) (19)
- Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia (2017) (19)
- Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs. (2011) (18)
- Neuroendocrine markers in aging brain: Clinical and neurobiological significance of dexamethasone suppression test (1990) (18)
- Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation (2014) (18)
- Anticholinergic burden and functional status in older people with cognitive impairment: Results from the ReGAl project (2016) (18)
- Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis (2018) (18)
- Automatically computed rating scales from MRI for patients with cognitive disorders (2019) (18)
- Senotherapeutics: Targeting senescent cells for the main age-related diseases (2021) (18)
- CSF monoamine metabolites in old age dementias. (1992) (18)
- A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort. (2016) (18)
- Arginine vasopressin in the cytoplasm and nuclear fraction of lymphocytes from healthy donors and patients with depression or schizophrenia (2001) (18)
- Does the 15-item Geriatric Depression Scale function differently in old people with different levels of cognitive functioning? (2018) (18)
- Cathepsin D Polymorphism in Italian Elderly Subjects with Sporadic Late-Onset Alzheimer’s Disease (2003) (18)
- Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease (2017) (18)
- Peripheral non-enzymatic antioxidant changes with human aging: A selective status report (2004) (17)
- Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease (2020) (17)
- Platelet MAO-B activity and vitamin B12 in old age dementias. (1992) (17)
- Urinary metabolic phenotyping for Alzheimer’s disease (2020) (17)
- Pathogenetic mechanisms in vascular dementia (1994) (16)
- Neuropsychological assessment of the severely impaired elderly patient: Validation of the Italian short version of the Severe Impairment Battery (SIB) (1999) (16)
- Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study (2013) (16)
- Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC) (2019) (16)
- Physical activity and cardiovascular health in the elderly (1998) (16)
- Prevalence of aging-associated cognitive decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer's disease (IPREA). (2010) (16)
- Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. (2006) (16)
- Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association. (2009) (16)
- Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. (2022) (15)
- Pain and Frailty in Hospitalized Older Adults (2020) (15)
- Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer’s Disease (2019) (15)
- Is the 15-item Geriatric Depression Scale a Fair Screening Tool? A Differential Item Functioning Analysis Across Gender and Age (2018) (15)
- Cognitive Enhancement Therapy for Alzheimer’s Disease (1997) (15)
- Impact of the earthquake of September 26, 1997 in Umbria, Italy on the socioenvironmental and psychophysical conditions of an elderly population (2000) (14)
- Effects of Weekly Supplementation of Cholecalciferol and Calcifediol Among the Oldest-Old People: Findings From a Randomized Pragmatic Clinical Trial (2019) (14)
- Hyperhomocysteinemia and oxidative stress in ischemic stroke. (2001) (14)
- Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts (2013) (14)
- Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project. (2017) (14)
- Hypovitaminosis D: A Disease Marker in Hospitalized Very Old Persons at Risk of Malnutrition (2019) (14)
- Association of increased carotid intima–media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer’s disease (2015) (14)
- Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe (2021) (14)
- Glutathione Serum Levels and Rate of Multimorbidity Development in Older Adults (2019) (13)
- Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
- Oxidative stress and dementia: new perspectives in AD pathogenesis (1997) (13)
- Version abrégée de la severe impairment battery (SIB) (2003) (13)
- Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy? (2018) (13)
- Uric acid and late-onset Alzheimer’s disease: results from the ReGAl 2.0 project (2020) (12)
- Classification Models for Alzheimer's Disease Detection (2013) (12)
- Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study. (2017) (12)
- Normative data for the ACE-R in an Italian population sample (2015) (12)
- Area-Specific Differences in OH8dG and mtDNA4977 Levels in Alzheimer Disease Patients and Aged Controls (1999) (11)
- Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease. (2019) (11)
- INCREASED OXIDATIVE DAMAGE IN LYMPHOCYTES OF ALZHEIMER'S DISEASE PATIENTS (1997) (11)
- Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type (2006) (11)
- Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No? (2017) (10)
- Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group. (1989) (10)
- Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics (2013) (10)
- The Effects of Aging and Endurance Exercise on Cardiovascular Performance in Healthy Elderly: A Review of the Literature. (1998) (10)
- The Treviso Dementia (TREDEM) Study: A Biomedical, Neuroradiological, Neuropsychological and Social Investigation of Dementia in North-Eastern Italy. (2012) (10)
- Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia (2020) (10)
- PLASMA LIPID PEROXIDATION AND VITAMIN C STATUS IN HEALTHY CENTENARIANS (1999) (10)
- Effects of vitamin A administration on serum thyrotropin concentrations in healthy human subjects. (2002) (9)
- Prevalence of Aging-Associated Cognitive Decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer’s disease (IPREA) (2010) (9)
- Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease (2014) (9)
- Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts. (2015) (9)
- Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific "Cytokinome Signature". (2019) (9)
- Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project (2020) (9)
- Modeling the dynamics of energy imbalance: The free radical theory of aging and frailty revisited. (2022) (9)
- The impact of aging in dementia: It is time to refocus attention on the main risk factor of dementia (2020) (9)
- Antioxidant Agents in Alzheimers Disease (2008) (9)
- The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians. (2000) (8)
- Effect of Acetyl-L-Carnitine on Serum Levels of Cortisol and Adrenocorticotropic Hormone and Its Clinical Effect in Patients with Senile Dementia of Alzheimer Type (1990) (8)
- Medico-legal assessment of personal damage in older people: report from a multidisciplinary consensus conference (2020) (8)
- The Importance of Cellular Senescence in Frailty and Cardiovascular Diseases. (2020) (8)
- Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia. (2020) (7)
- Fatigue as a clinical sign of biological aging: exploratory analyses from the MINDED project (2016) (7)
- Dementia, depression and parkinsonism: A frequent association in the elderly. (2001) (7)
- MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain (2020) (7)
- No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease. (2017) (7)
- Telomeres Increasingly Develop Aberrant Structures in Aging Humans. (2018) (7)
- Italian version and normative data of Addenbrooke's Cognitive Examination III (2018) (6)
- Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain (2019) (6)
- CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease (2013) (6)
- Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model (2020) (6)
- cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders (2020) (6)
- Exome sequencing identifies rare damaging variants in the ATP8B4 and ABCA1 genes as novel risk factors for Alzheimer’s Disease (2020) (5)
- O1-06-02 The caregiver burden inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study (2004) (5)
- Studies on Alzheimer's Disease (2013) (5)
- Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease (2022) (5)
- [Abridged version of the severe impairment battery (SIB)]. (2003) (5)
- Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids. (2019) (5)
- Il progetto Europeo K4CARE (Knowledge-Based HomeCare eServices for an Ageing Europe): un sistema intelligente per l'assistenza domiciliare all'anziano (2004) (5)
- Superficial Siderosis of the Central Nervous System: A 70-Year-Old Man with Ataxia, Depression and Visual Deficits (2001) (5)
- CERAD memory composite score is an accurate neuropsychological predictor of progression to Alzheimer's disease: AddNeuroMed study (2011) (4)
- Lack of Energy and Negative Health-Related Outcomes in Nursing Home Residents: Results From the INCUR Study. (2016) (4)
- Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
- Validation study of the Italian version of Communication Activities of the Daily Living (CADL 2) as an ecologic cognitive assessment measure in older subjects (2019) (3)
- DATA-DRIVEN DIAGNOSIS OF DEMENTIA DISORDERS: THE PREDICTND VALIDATION STUDY (2017) (3)
- User experience and acceptance of a device assisting persons with dementia in daily life: a multicenter field study (2021) (3)
- Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review (2015) (3)
- Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD (2022) (3)
- Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer’s models (2022) (3)
- Fetal variant of circle of the Willis and bilateral symmetrical parietal stroke (2012) (3)
- Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology (2020) (3)
- Blood pressure and functional aspects of the aging brain. (1989) (3)
- Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients. (2019) (3)
- The aging caregiver in the aged world of dementia (2017) (3)
- Oxidative stress and lymphocytes in Alzheimer disease (1998) (3)
- P2-206 Functional decline in mild cognitive impairment. Results from the regal project (2006) (2)
- MicroRNA biomarkers in Alzheimer's disease (2013) (2)
- Mining clinical and laboratory data of neurodegenerative diseases by Machine Learning: transcriptomic biomarkers (2018) (2)
- Plasma antioxidants and oxidative DNA damage in lymphocytes from normal aged people and Alzheimer disease patients (2000) (2)
- Low Levels of 4977 BP‐deleted Molecules of Mitochondrial DNA in the Presence of High OH8DG Contents in Healthy Subjects and Alzheimer's Disease Patients (1998) (2)
- Metabolic Score for Insulin Resistance (METS-IR) and Circulating Cytokines in Older Persons: The Role of Gender and Body Mass Index (2022) (2)
- ePresentation Sessions (2018) (2)
- Dealing with dehydration in hospitalized oldest persons: accuracy of the calculated serum osmolarity (2022) (2)
- Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type (2010) (2)
- The Multifaceted Aspects of Alzheimer's Disease: From Social to Molecular Problems (2007) (2)
- Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s disease (2021) (2)
- Lower serum levels of IL-13 is associated with increased carotid intima-media thickness in old age subjects (2019) (2)
- Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) (2021) (2)
- K4care: a new intelligent system for home care (2008) (2)
- Music Therapy Effects in People with Dementia (2019) (2)
- Subjective memory complaints and depression as clinical symptoms of disseminated nocardiosis by Nocardia abscessus (2016) (2)
- Nutraceuticals and Cognitive Dysfunction (2017) (2)
- Biomarkers of dementia: from bench to clinical side (2018) (2)
- Effect of Mediterranean Diet on Healthy Brain Aging: Involvement of Telomerase (2018) (2)
- Oxidative stress in Alzheimer's disease: a selective status report (2004) (2)
- Cluster Analysis and Decision Trees of MR Imaging in Patients Suffering Alzheimer's (2010) (2)
- Telomerase activation and human health-span: an open issue (2018) (2)
- P1-019 Behavioral and psychological symptoms in dementia: a population-based study (2004) (1)
- Review Article Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease (2016) (1)
- Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. (1997) (1)
- ePoster Sessions (2018) (1)
- Advanced Research in Telomeres and Disease Risk (2017) (1)
- Topics in clinical pharmacology: cardiovascular and diabetes mellitus. (2010) (1)
- Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium (2022) (1)
- DETECTING FRONTOTEMPORAL DEMENTIA USING A NOVEL MRI IMAGING BIOMARKER: THE ANTERIOR VERSUS POSTERIOR INDEX (2018) (1)
- Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation (2012) (1)
- Fighting social isolation in times of pandemic COVID-19: the role of video calls for older hospitalized patients (2022) (1)
- The orthogeriatric management: an inseparable duo to foster appropriate care (2016) (1)
- P2-203 Amnestic mild cognitive impairment or very mild Alzheimer’s disease? Results from the ReGAl project (2006) (1)
- Usability testing of the first prototype of the Memento system: a technological device to promote an independent living in people with dementia. (2022) (1)
- “Oldest old” man with odynophagia and generalized asthenia: It could be tetanus! (2016) (1)
- Multivariate Data Analysis Of Regional MRI Volumes and Cortical Thickness Measures To Distinguish Between Alzheimer's Disease, Mild Cognitive Impairment And Healthy Controls (2009) (1)
- The “Artwork Effect” paradigm: A model for planning and assessing cognitive stimulation for people with dementia through museum visits (2018) (1)
- Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders (2021) (1)
- ABNORMAL NETWORK ORGANIZATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE (2016) (1)
- A blast from the past: To tame time with metformin (2022) (1)
- P4-235 Protein oxidation, lipid peroxidation and antioxidant status are similarly altered in Alzheimer disease and vascular dementia (2004) (1)
- Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
- The orthogeriatric comanagement improves clinical outcomes compared with consultant geriatric service and traditional model (2013) (1)
- Poster Session‐Sunday (2016) (1)
- O1-06-01 Cognitive impairment is the major risk factor of adverse events in hospitalised elderly patients (2004) (1)
- UNDERDIAGNOSIS AND UNDERTREATMENT OF NURSING HOME RESIDENTS AT HIGH RISK FOR FRAGILITY FRACTURES (2016) (1)
- Gait as predictor of dementia (2017) (1)
- Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study (2019) (1)
- Plasma longitudinal changes of carotenoids and malondialdehyde in stroke patients: relationship to outcome (2001) (1)
- Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (1)
- Extreme longevity: the role of antioxidant enzymes, vitamins, and micronutrients. (2001) (1)
- Stability of graph theoretical measures in structural brain networks in Alzheimer’s disease (2018) (1)
- Ultrasensitive blood biomarkers to predict cognitive decline and diagnose Alzheimer’s disease in the absence of AT(N) classification as the reference standard (2020) (1)
- The interdisciplinary fracture liaison service improves health-related outcomes and survival of older adults after hip fracture surgical repair (2022) (1)
- Plasma levels of vitamin E isoforms and of coenzyme Q10 in cognitively normal, MCI and AD (2009) (0)
- Association of magnetic resonance imaging white matter lesions and cognitive decline in Alzheimer's disease (2013) (0)
- Common brain disorders are associated with heritable patterns of apparent aging of the brain (2019) (0)
- Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both (2023) (0)
- COVID-19: when, along with aging, sex matters (2020) (0)
- Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation (2014) (0)
- Combining Two Large MRI Data Sets (AddNeuroMed and ADNI) Using Multivariate Data Analysis to Distinguish between Patients with Alzheimer's Disease and Healthy Controls (2010) (0)
- Contents Vol. 18, 2004 (2004) (0)
- A LONGITUDINAL STUDY OF AN MRI BASED SEVERITY INDEX IN THE ADDNEUROMED COHORT (2014) (0)
- Hypomagnesemia and incident delirium in hospitalized older persons (2023) (0)
- 747 Evaluation of 8-hydroxydeoxyguanosine in leukocytes of AD Patients (1996) (0)
- Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease (2021) (0)
- VKučinskas-2001-2016 (2016) (0)
- Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease (2021) (0)
- DETECTING ALZHEIMER’S DISEASE AT DIFFERENT LEVELS OF WHITE-MATTER HYPERINTENSITIES USING MRI (2019) (0)
- O1-03-03 From mild cognitive impairment to Alzheimer’s disease: Preliminary results of a 1H-MRS longitudinal study (2006) (0)
- TOWARDS DATA-DRIVEN MEDICINE IN DIFFERENTIAL DIAGNOSTICS OF NEURODEGENERATIVE DISEASES (2016) (0)
- Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes (2022) (0)
- Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease (2019) (0)
- Cortical thinning patterns in Alzheimer's patients and subjects with mild cognitive impairment from the AddNeuroMed study (2011) (0)
- A prospective validation study of the predictnd tool: A diagnostic decision support tool—rationale and design of the study (2015) (0)
- COMPARING CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN DIFFERENT COHORTS (2014) (0)
- [Impact of population aging on the social and the health care system: need for a new model of long-term care]. (2003) (0)
- P4-042: Plasma levels of vitamin E isoforms and of coenzyme Q10 in cognitively normal, mild cognitive impairment and Alzheimer's disease elderly subjects: Preliminary results from the addneuromed project (2008) (0)
- Fracture and dementia: from epidemiological to biological connections (2016) (0)
- Interest in hearing loss in geriatric medicine: a survey of members of the Societa' Italiana Geriatria Ospedale e Territorio (SIGOT) (2022) (0)
- Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy (2022) (0)
- P1-434 Apathy and depressive symptoms in Alzheimer’s disease. Results from the European Alzheimer’s Disease Consortium (2006) (0)
- DISTINCT NEURAL SIGNATURES OF DIFFERENT APOE GENE POLYMORPHISMS ON HIPPOCAMPAL VOLUME: A LARGE SCALE STUDY IN ALZHEIMER'S DISEASE AND NORMAL HEALTHY AGEING (2014) (0)
- Detection of cognitive disorders using web-based cognitive test battery: Validation against traditional methods (2017) (0)
- P3-114 Comorbidity and polipharmacotherapy in dementia: the regal project in Italy (2004) (0)
- Prevention of Age-Related Cognitive Impairment, Alzheimer’s Disease, and Dementia (2020) (0)
- Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease (2017) (0)
- Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients (2009) (0)
- P4-208 Use and underuse of drugs in old non demented and demented people: Preliminary results of the ReGal Project (2006) (0)
- The pitfall of GWA in Alzheimer disease: an Italian case-control study (2016) (0)
- Decreased dehydroepiandrosterone and dehydroepiandrosterone sulphate in Alzheimer's disease (2007) (0)
- P1-246 Medical comorbidity in dementia: From the ReGAl project in Italy (2006) (0)
- Impact of White Matter Hyperintensities on progression in Alzheimer's disease Comparison of Amyloid Biomarkers in Alzheimer's Disease-a Monocentric Study (2018) (0)
- Decreased expression and increased carbonylation of haptoglobin in plasma from MCI and AD subjects: Role of extracellular chaperones in Alzheimer’s disease (2012) (0)
- Subject Index Vol. 18, 2004 (2004) (0)
- A genotype risk score based on Type 2 diabetes risk factors is associated with lower risk for Alzheimer's disease in APOE e4 carriers (2011) (0)
- Biological profile of subjects with vascular successful aging: The VaSA study (1999) (0)
- P2-175 Role of proton magnetic resonance spectroscopy (1H-MRS) in predicting the conversion of mild cognitive impairment to dementia (2004) (0)
- AI-Based Predictive Modelling of the Onset and Progression of Dementia (2022) (0)
- Blood-based biomarker discovery using aptamer capture (SOMAscan) platform technology (2013) (0)
- An integrated model for the management of patients with dementia: From prevention to care (2015) (0)
- The reliability of a deep learning model in external memory clinic MRI data: A multi‐cohort study (2020) (0)
- Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage Neuroimaging (2015) (0)
- Contents Vol. 24, 2007 (2007) (0)
- SHORT-TERM RESPONSE IS NOT PREDICTIVE OF LONG-TERM RESPONSE TO ACETYLCHOLINESTERASE INHIBITORS IN OLD AGE SUBJECTS WITH ALZHEIMER’S DISEASE: A ‘REAL WORLD’ STUDY (2017) (0)
- Addenbrooke’s Cognitive Examination III--Italian Version (2020) (0)
- DIFFERENT COMBINATIONS OF DIAGNOSTIC TESTS DISCRIMINATE SPECIFIC SUBTYPES OF DEMENTIA (2018) (0)
- A validation study of VCI genetics meta-analysis findings in a large collaborative cohort (2013) (0)
- Plasma inflammatory markers correlate with severity in Alzheimer's disease (2012) (0)
- The Questionable Role of GWA in Identification of Genetic Risk Factors for Alzheimer’s Disease (P5.165) (2016) (0)
- Subject Index Vol. 24, 2007 (2007) (0)
- Water intake, hydration and Parkinson’s disease (2022) (0)
- Biomarker Based and Individualized Prognosis for Patients with Mild Cognitive Impairment: Towards a Personalized Medicine Approach for AD (2019) (0)
- Differential diagnosis of dementia combining web‐based cognitive testing and MRI (2020) (0)
- Contents Vol. 24, 2007 (2007) (0)
- P1-291: Early magnetic resonance imaging results from the addneuromed Alzheimer's disease study (2008) (0)
- O3-01-05 Aconitase activity in lymphocyte mitochondria from AD, MCI and cognitively normal subjects (2006) (0)
- Plasma‐based biomarkers for Aβ and tau predict longitudinal brain atrophy in cognitively healthy elderly and in patients with Alzheimer’s disease (2020) (0)
- Serum interleukin-6 levels are higher in old age subjects with Alzheimer’s dementia (2021) (0)
- DPP-4 inhibitors: meeting the needs of the very old population (2019) (0)
- Plasma inflammatory markers correlate with severity in Alzheimer's disease (2010) (0)
- Italian guidance on Dementia Day Care Centres: A position paper (2023) (0)
- Preclinical phase of Alzheimer's disease: Guideline for recognition and study of patients with mild cognitive impairment (2002) (0)
- Editorial for the Special Issue “Molecular Bases of Senescence” (2021) (0)
- Addenbrooke’s Cognitive Examination--Revised Version; Italian Version (2020) (0)
- The correlates of post-surgical haematoma in older adults with proximal femoral fractures (2023) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Performance cognitive in pazienti anziani sottoposti a endoarterectomia o a stenting carotideo: Studio di follow up a 12 mesi (2010) (0)
- Resting State Connectivity in Posterior Cingulate and Hippocampus in Mild Alzheimer’s (2011) (0)
- Chapter 10. Nutraceuticals in Neurodegenerative Diseases (2020) (0)
- Genome-wide association analysis identifies common variants associated with measures of disease progression in patients with Alzheimer's disease (2012) (0)
- Multivariate Analysis of MRI Data to Discriminate between Groups and Predict Conversion in Alzheimer's Disease (2010) (0)
- Sub-acute physical and mental decline associated with abnormally hypercalcemia: the case report of an oldest-old woman saved by surgery (2019) (0)
- DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS (2017) (0)
- Subject Index Vol. 24, 2007 (2007) (0)
- P1‐165: Withdrawn (2015) (0)
- Dementia in the old age: a gloomy wood later in life (2018) (0)
- A stepwise approach towards diagnostic workup in dementia using online cognitive tools (2021) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4 (2022) (0)
- Publisher Correction: Pattern of Altered Plasma Elemental Phosphorus, Calcium, Zinc, and Iron in Alzheimer’s Disease (2019) (0)
- The vitamin E family in Alzheimer's disease and mild cognitive impairment: Results from the AddNeuroMed study (2011) (0)
- Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project. (2021) (0)
- Cortical atrophy rates in Alzheimer's patients and subjects with mild cognitive impairment from the AddNeuroMed data collection (2010) (0)
- Attention, Praxis, and Reasoning Are Associated with Risk of Undernutrition in Older People with Cognitive Impairment. (2022) (0)
- P3-470: Relationship between caregiver distress and falls in elderly subjects with dementia (2008) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- COST-EFFICIENT DIFFERENTIAL DIAGNOSTICS OF NEURODEGENERATIVE DISEASES USING A STRATIFIED APPROACH (2016) (0)
- Tocopherols And Tocotrienols Plasma Levels And The Risk Of Alzheimer's Disease In The Oldest Old: Results From The Kungsholmen Project (2009) (0)
- Communication Activities of the Daily Living--2nd Edition; Italian Version (2021) (0)
- Cholinesterase inhibitors in dementias (2020) (0)
- Dementia and delirium (2016) (0)
- miRNAs and Alzheimer’s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population (2023) (0)
- Clinical physiology-pharmacology: Age-disease-drug-related hypernatremia and hyperphosphatemia (1995) (0)
- No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease. (2015) (0)
- Acknowledgment to our referees (2009) (0)
- DETECTING COGNITIVE DISORDERS USING MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS (2017) (0)
- Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD (2022) (0)
- Effect of neurobehavioural symptoms on disability in Alzheimer's disease (2004) (0)
- Voxel-based assessment of asymmetrical hippocampal and entorhinal atrophy in MCI: A longitudinal MRI investigation from the addneuromed study (2010) (0)
- Upcoming Meetings Related to Alzheimer's Disease. (2007) (0)
- MEMORY ABILITIES IN HEALTHY ELDERLY SUBJECTS: A FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY (2002) (0)
- Therapy of Alzheimer’s Dementia (1998) (0)
- Protective variant for rate of hippocampal volume loss identified by whole exome sequencing in APOE-ε3ε3 males with MCI (2013) (0)
- Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease. (2020) (0)
- P4-089: Vitamin E plasma level and risk of dementia: Results from the Kungsholmen Project (2008) (0)
- DMapp: a developing promising approach to monitor symptoms progression and stimulate memory in Italian people with cognitive impairments (2022) (0)
- Oral and Poster Papers Submitted for Presentation at the 5th Congress of the EUGMS “Geriatric Medicine in a Time of Generational Shift September 3–6, 2008 Copenhagen, Denmark (2008) (0)
- Genetic influences on metabolite levels in Alzheimer’s disease (2015) (0)
- IMPACT OF BIOMARKERS ON DIAGNOSTIC CONFIDENCE IN CLINICAL ASSESSMENT OF PATIENTS WITH SUSPECTED ALZHEIMER'S DISEASE AND HIGH DIAGNOSTIC UNCERTAINTY: AN EADC STUDY (2016) (0)
- MS504 ZINC–GENE INTERACTIONS ON INFLAMMATION AND RISK TO DEVELOP CVD IN THE ELDERLY (2010) (0)
- The brain of the elderly between normality and pathology: techniques and technologies for the evaluation. (2001) (0)
- Peripheral signatures of the clusterin-DKK neurotoxicity pathway as potential blood-based biomarkers (2013) (0)
- Visual disturbances in a young Alzheimer's disease patient: Clinical (1998) (0)
- O1-02-08: The innomed/addneuromed framework for multicenter MRI assessment of longitudinal changes in Alzheimer's disease (2008) (0)
- The Effect of Age Correction on Multivariate Classification in Alzheimer’s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects (2015) (0)
- [0091]Analysis of HO-1/BVR post translational modifications as potential plasma biomarker of Alzheimer’s disease (AD) pathology (2012) (0)
- IC-P-091 ANALYSIS OFCEREBRALLOBARMICROBLEEDS AND DECREASED CEREBRAL BLOOD FLOW IN A MEMORY CLINIC SETTING (2014) (0)
- CONSISTENCY OF MUISTIKKO WEB-BASED COGNITIVE TEST WHILE PERFORMED AT CLINIC AND AT HOME (2018) (0)
- Vitamin D supplementation with calcidiol and cholecalciferol among oldest-old persons (2016) (0)
- Using the Geriatric Depression Scale-Short Form with cognitively normal and cognitively impaired individuals: an IRT-based DIF analysis (2016) (0)
- COMPARING CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN DIFFERENT COHORTS (2014) (0)
- An Item Response Theory (IRT) study of the Geriatric Depression Scale-Short Form (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Patrizia Mecocci?
Patrizia Mecocci is affiliated with the following schools:
